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Abstract
Lencucha and Thow’s paper offers an important addition and corrective to the burgeoning body of work in public 
health on the ‘commercial determinants of health’ in the context of non-communicable diseases (NCDs). Rather 
than tracing the origins of incoherence across policy sectors to the nefarious actions of industry, they argue 
that we need to be better attuned to the neoliberal ideologies that underpin these policies. In this commentary 
I explore two aspects of their argument that I find to be problematic: First, the suggestion that neoliberalism 
itself has some kind of deterministic or explanatory capacity across vastly different social, spatial, economic and 
political contexts. Second, I explore their concept of ‘product-based NCD risk,’ a perspective that disembodies 
and detaches risk from the social and structural conditions of their making. 
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Lencucha and Thow’s paper has a laudable goal: to explore and explain policy (in)coherence – within and between the health and economic sectors – pertaining 
to what they term ‘product-based non-communicable disease 
(NCD) risk.’1 In the authors’ commentary, such ‘policy 
incoherence’ refers to the decoupling of economic policy 
from social and health policy. As they then argue, where the 
means and ends of health and economic policies deviate, this 
has often been explained by the ‘nefarious strategies used by 
industry to promote unhealthy products and prevent their 
regulation.’1 Recently, such research and writing has been 
undertaken under the frame of the ‘commercial determinants 
of health.’2,3 While there is great truth in the belief that the 
strategies of big business can be immoral and detrimental to 
human health, Lencucha and Thow suggest that there is more 
underpinning the story than the corporate conspiracies that 
often accompany public health analyses of the commercial 
determinants of (poor) health. 
Their paper argues that ‘the friction that inhibits healthy 
product policy regimes is the persistence of the neoliberal 
paradigm in shaping the relationship between government, 
market and society.’1 They further contend that we need to 
embed ‘products in this broader policy context’1 in order to 
better understand the paradigms that underpin institutional 
landscapes. At this paper’s core, therefore, is the assertion 
that in order to understand policy incoherence, we must first 
appreciate and interrogate the tight grip of the neoliberal 
policy paradigm across the world and how this, in turn, 
shapes divergent expectations of the relationship between the 
state, markets and consumer-citizens. This paradigm, they 
argue, is a barrier to health and economic policy coherence 
given that the aspirations of neoliberalism – a free market 
untethered from state intervention, less Government but 
more governance, the value of privatisation and a belief 
in the sanctity of individual autonomy (rather than social 
responsibility) – are almost always incompatible with the 
kinds of social and health policies that are needed to ensure 
universal well-being. 
These are undeniably important interventions for those in 
public health who have become increasingly attuned to seeking 
out the nefarious rather than questioning the prevailing 
ideology or ideologies that might undergird and justify this.4,5 
Stepping back from the front line of these vested interests is 
also essential in order to start to carve out more nuanced and 
qualitative engagements with the role that industries play in 
shaping our health outcomes and how governments and their 
policy choices might enable or constrain these.6,7 However, 
as Bell and Green’s8 recent editorial in Critical Public Health 
should remind us, public health’s often-reductionist tendency 
to evoke deterministic narratives of neoliberalism as a catch-
all explanation for everything that is wrong with the private or 
public sectors’ approach to health often lacks the spatial and 
social nuance, as well as qualitative depth, that many social 
scientists have argued for. This marks the first of my two 
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avenues of critique of this paper. 
Lencucha and Thow’s assertion that, first, neoliberalism has 
become ‘the dominant paradigm’1 and that second, this ‘has 
conditioned the policy environment in a way that promotes 
the supply of unhealthy commodities’1 is to fall into the trap 
identified by Ward and England9 of casting neoliberalism as 
an ideological hegemon. Here I argue that, in keeping with 
the arguments made by Brenner and Theodore,10 neoliberal 
projects are not only multiple, they are also embedded within 
particular geographic, social and economic contexts which, 
in turn, condition the particularities of their emergence and 
deployment. To state the obvious, while both France and the 
United States are neoliberal economies, the social contract 
between citizens and government is vastly different in each. 
As such, they do not share a universal conception or ideology 
of the relationship between the state, market and citizens. 
This is especially the case in the domain of health. And, 
while Lencucha and Thow clearly accept that the neoliberal 
paradigm is not uniformly applied, they do insist that, as a 
‘dominant’ political, social and economic ideology, its uptake 
holds huge explanatory weight. As they further suggest, if 
this is acknowledged and understood by health advocates, 
then they can be ‘more sympathetic to policy-makers’1 across 
the sectors that are often so heavily critiqued within the 
commercial determinants of health mindset. 
My concern is that such reductionism is largely 
unrepresentative of the vastly different ways in which health 
plays into and is an outcome of the market-state-citizen nexus 
across the world. Tracing policy incoherence to neoliberal 
ideology also lends credence to the belief that there can be 
universal ‘best-buys’ or policy-solutions to solve the world’s 
NCD woes.11 Yet, there is no one neoliberal paradigm, no 
one set of neoliberal policies and certainly no unifying 
experience of living in a neoliberal society. The suggestion 
that the dynamic intricacies of ‘policy incoherence’ are a 
‘logical extension to’1 the tentacles of neoliberal ideology 
supports the assertion that ‘evidence-based’ best buys can 
be unproblematically transferred across the world. Yet, as 
Brenner and Theodore make clear, ‘the global imposition 
of neoliberalism has been highly uneven, both socially and 
geographically and its institutional forms and sociopolitical 
consequences have varied significantly across spatial 
scales.’10 Rather than seeking the out the explanatory power 
of a ‘dominant ideology,’ greater attention is needed to the 
social, economic and political contexts that help explain 
why the application of best buys can often have unintended 
consequences. 
To talk or write of neoliberalism as if it was a coherent 
and universally-agreed ideology with a clearly demarcated 
channel to policy outcomes is, I suggest, to thoroughly miss 
its ‘polycentric and multiscalar character.’10 It is important 
to remember that citizens (whose voices are often neglected 
by Luncucha and Thow) can also have hugely divergent 
expectations of individual liberty and freedom to consume 
‘unhealthy’ products within neoliberal economies. Reducing 
policy incoherence to a singular neoliberal paradigm offers 
partial insight, but my fear is that it also reinforces a public 
health tendency to talk about the world in vastly generalised 
terms. For example, the example used in the paper that rolls 
together alcohol policy across the vastly different countries 
of Lesotho, Uganda, Malawi, and Botswana12 misses an 
important counter-factual – that Botswana’s 70% alcohol levy 
and tight regulation of traditional beer depots was decidedly 
anti-neoliberal in the state’s regulatory approach, much to the 
dismay of liquor producers and retailers.13 This example is 
but one, but serves to problematise any assertion that there 
can ever be a ‘logical extension of the neoliberal paradigm.’1 
Instead, we see only the ‘bricolage’ of policy experiments and 
failures that may be underpinned to a greater or lesser extent 
by a series of (often inconsistent and illogical) views of how 
the state, market and society should interrelate.14
My second line of critique follows Lencucha and Thow’s 
fascinating use of the term ‘product-based NCD risk.’ It is 
clear that many products are bad for our health – alcohol, 
ultra-processed foods, too much salt, tobacco – yet, there is 
something about appending risk to the product alone that, 
as a social scientist, I find curious. Conjoining the terms 
‘product-based NCD risk’ suggests that products alone are a 
risk factor for NCDs or that the aetiology of NCDs can be 
traced to products. Yet, products are purchased and consumed 
in contexts and environmental settings that far outstrip the 
capacity of the product alone to be harmful. For example, while 
alcohol consumption in the United Kingdom may be highest 
amongst professional classes, alcohol-attributable harms are 
highest amongst those of lower socioeconomic status: the 
‘alcohol harm paradox.’15 The authors do also consider ‘the 
management of product environments,’1 but this term itself is 
equally restrictive and reductive. Indeed, just as neoliberalism 
is produced in and through certain socio-spatial contexts, the 
risk of developing a chronic disease cannot be reduced to a 
set of (harmful) products and ‘product environments.’ This 
is especially so as the term ‘product environment’ reduces 
the nature of the ‘environment’ to product formulation, 
marketing strategies and corporate efforts to evade regulation 
rather than the broad socio-ecological contexts more often 
associated with the term. To focus attention on the ‘product 
environment’ is thus, ironically, to miss the actual environment 
in all its holistic complexity. 
The perils of ascribing risk to individual or group lifestyles 
in terms of associated stigma or discrimination are well-
documented across infectious diseases16 and NCDs.17 Yet, 
theorising risk in terms of products – as often the case within 
the expanding research domain of the corporate determinants 
of health – also comes with its own moral perils. While the frame 
ably draws attention to the nefarious actions of industry, it can 
also have a flipside. For example, the demonisation of certain 
products within public health discourse and policy (ie, high-
strength cider within the alcohol minimum pricing debate in 
the United Kingdom) inevitably stigmatises those who choose 
to consume it and can legitimise a silence on the broader 
drivers of these practices by prioritising the elimination of 
demand for the product. Attention to the wrongdoings of 
industry, the policy paradigms that may support these and 
their health consequences is essential. However, this should 
not be at the expense of drawing attention to the broader 
structural and social conditions that shape the contexts within 
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which buying (or not buying) ‘unhealthy commodities’18 takes 
place. Doing so helps illuminate why ‘product-based NCD 
risk’ is never universally borne and why critical attention to 
environments other than those circumscribed by products 
alone needs to be far more wide-ranging. 
The conversations about health risk, systems and beliefs 
that Lencucha and Thow are initiating through their paper 
are crucial. Similarly, their efforts to draw attention to the 
underlying systems of thought that guide a consistent and 
frustrating state of policy incoherence are long overdue 
within the public health field. That economic and health or 
social policies are at odds should come as no shock given 
the sacrifices expected of the social realm in the name of 
economic growth and productivity. Yet, focussing attention 
on ‘the product environment’ in relation to NCDs may 
inadvertently provide even more of a role for industry: it 
sanctions product reformulation, revised marketing strategies 
or entirely new ‘better for you’ products. Indeed, exploring 
neoliberalism through products in the context of health 
may further disembed and decontextualise the social issues 
of real importance. With political horizons as short-term as 
our individual risk-horizons, the ‘crisis’ of NCDs will only 
continue to grow. There are many things to blame for this 
and neoliberal ideology is but one. Within public health, it is 
important to avoid the temptation to suggest that it is the one.8 
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